Cai G (2020).Tobacco-use disparity in gene expression of ACE2, the receptor of 2019-nCov COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
ATS International Task Force (03/04/2020). COVID‐19 Interim Guidance on Management Pending Empirical. Tratamientos e interacciones farmacológicas / 25 de Abril del 2020 Read more
Amgalan A (2020). Letter to de Editor ExPloring possible mechanisms for COVID-19 induced thrombocytopenia Unanswered Questions COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Yin S. et al. (2020). Diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
GOLD COVID-19. Recomendaciones EPOC COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
Vardavas C (2020). COVID-19 and smoking: A systematic review of the evidence COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
SETH (24/03/2020). Recomendaciones control anticoagulacion-Covid-19 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Wenzhog L (2020). COVID-19 Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Gheblawi M. et al. (2020). Angiotensin Converting Enzyme 2 SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
GINA 2020 (19/03/2020). Recomendaciones medicación asma inhalada COVID19 COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more